A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants with Macular Edema Secondary to Inflammation (MESI)
Macular Edema Secondary to Inflammation (MESI) with a central subfield thickness... [+2]
ME in the Study Eye secondary to diabetes, RVO, or wAMD. [+2]